People who perhaps are thin might never think about food the way people who have obesity [do]. Its why advice to just diet and exercise can fall short for people with obesity theyve likely tried, and it was not effective or sustainable on their own
Your provider monitors how you respond, adjusts timing, and watches for problems you might not notice yourself
Dual GLP-1/GIP receptor agonists, such as tirzepatide, potentiate glycemic control, weight reduction, and metabolic improvement through synergistic receptor activation
Injection sites include your abdomen (at least 2 inches from navel), front of your thigh, and upper arm (if someone else is administering)
Gastrointestinal side effects may be intensified when these medications are used together